| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/20/2011 | US20110014667 Producing Dicarboxylic Acids Using Polyketide Synthases |
| 01/20/2011 | US20110014666 Polypeptide having glyoxalase iii activity, polynucleotide encoding the same and uses thereof |
| 01/20/2011 | US20110014662 Methods for producing hyaluronan in a recombinant host cell |
| 01/20/2011 | US20110014660 Thermostable dna polymerase from palaeococcus ferrophilus |
| 01/20/2011 | US20110014656 Soluble il-17ra/rc fusion proteins and related methods |
| 01/20/2011 | US20110014653 Production of antibodies in avian cells |
| 01/20/2011 | US20110014651 Method for high-level secretory production of protein |
| 01/20/2011 | US20110014634 Nucleic acids encoding t2r, a novel family of taste receptors |
| 01/20/2011 | US20110014628 Identification of Surface-Associated Antigens for Tumor Diagnosis and Therapy |
| 01/20/2011 | US20110014627 Method for determining antagonist activity to a cytokinin receptor |
| 01/20/2011 | US20110014622 Genetic reference materials |
| 01/20/2011 | US20110014612 Polymerase compositions & methods |
| 01/20/2011 | US20110014608 SCREENING FOR CD93 (C1qRp)-ASSOCIATED POLYMORPHISM(S) IN THE DIAGNOSIS, PREVENTION AND TREATMENT OF AUTOIMMUNE DISEASES |
| 01/20/2011 | US20110014604 Methods for sequence determination |
| 01/20/2011 | US20110014601 Targeted Chromosomal Mutagenesis Using Zinc Finger Nucleases |
| 01/20/2011 | US20110014348 Soybean variety a1016117 |
| 01/20/2011 | US20110014341 Soybean variety a1016502 |
| 01/20/2011 | US20110014275 Compositions and methods for inhibiting or inducing adipogenesis |
| 01/20/2011 | US20110014242 Promoters for expression in modified vaccinia virus ankara |
| 01/20/2011 | US20110014236 Novel protein capable of inhibiting anthrax toxin activity |
| 01/20/2011 | US20110014232 Chimeric foot and mouth disease viruses |
| 01/20/2011 | US20110014229 Chimeric flavivirus vectors |
| 01/20/2011 | US20110014227 Pre-or post-exposure treatment for filovirus or arenavirus infection |
| 01/20/2011 | US20110014218 Ixodes scapularis salivary proteins and methods of use for modulation of the alternative complement pathway |
| 01/20/2011 | US20110014213 Human anti-alpha 9 integrin antibody |
| 01/20/2011 | US20110014210 Chlamydia vaccine |
| 01/20/2011 | US20110014201 Il-18 receptor antigen binding proteins |
| 01/20/2011 | US20110014199 Novel anti-il 13 antibodies and uses thereof |
| 01/20/2011 | US20110014193 Humanized anti-human alpha 9-integrin antibody |
| 01/20/2011 | US20110014187 Monoclonal antibodies capable of reacting with a plurality of influenza virus a subtypes |
| 01/20/2011 | US20110014172 Recombinant Human CLN2 Protein and Methods of Its Production and Use |
| 01/20/2011 | US20110014155 Reovirus for the Treatment of Cellular Proliferative Disorders |
| 01/20/2011 | US20110014152 Increased t-cell tumor infiltration and eradication of metastases by mutant light |
| 01/20/2011 | US20110014123 RNA interference mediating small RNA molecules |
| 01/20/2011 | US20110014117 Anti-igf1r |
| 01/20/2011 | DE102009033281A1 New polypeptide, comprising amino acid sequences, useful for the diagnosis of paraneoplastic neurological syndromes, autoimmune diseases and/or cancer |
| 01/20/2011 | CA2768343A1 Detoxified escherichia coli immunogens |
| 01/20/2011 | CA2768321A1 Microrna-24 |
| 01/20/2011 | CA2768318A1 Novel .delta.9-elongase for production of polyunsaturated fatty acid-enriched oils |
| 01/20/2011 | CA2768247A1 Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts |
| 01/20/2011 | CA2768241A1 A mechanism and method for regulating glycogen synthase kinase 3 (gsk3)-related kinases |
| 01/20/2011 | CA2768204A1 Gram-positive bacteria specific binding compounds |
| 01/20/2011 | CA2768133A1 Plants with modified lignin content and methods for production thereof |
| 01/20/2011 | CA2768082A1 Novel fatty acid desaturases and elongases and uses thereof |
| 01/20/2011 | CA2767972A1 Dual vector for inhibition of human immunodeficiency virus |
| 01/20/2011 | CA2767957A1 Regulation of zinc deficiency and tolerance in plants |
| 01/20/2011 | CA2767955A1 Method for determining the sensitivity or resistance of retrovirus isolates to molecules, therapeutic retroviral treatments based on viral protease inhibitors and diagnostic kits |
| 01/20/2011 | CA2767570A1 Mutated sumo isoforms and uses thereof |
| 01/20/2011 | CA2766871A1 Method for producing double haploid plants |
| 01/20/2011 | CA2766842A1 Enhancement of cellular production through mechanotransduction |
| 01/20/2011 | CA2766585A1 Production of fatty alcohols with fatty alcohol forming acyl-coa reductases (far) |
| 01/20/2011 | CA2766351A1 Chimeric primers with hairpin conformations and methods of using same |
| 01/20/2011 | CA2766065A1 Immunoglobulin fc polypeptides |
| 01/20/2011 | CA2764732A1 Plants having enhanced yield-related traits and a method for making the same |
| 01/20/2011 | CA2764073A1 Plant seeds with altered storage compound levels, related constructs and methods involving genes encoding cytosolic pyrophosphatase |
| 01/20/2011 | CA2759493A1 Method for screening for diet providing production of milk having immunoregulatory action |
| 01/19/2011 | EP2275818A2 Method for improved early recognition of the seroconversion of an antibody to hepatitis C |
| 01/19/2011 | EP2275579A2 Primer pair for the detection of a gene (VIP3A) encoding an insecticide |
| 01/19/2011 | EP2275577A1 Nucleic acid compaction method |
| 01/19/2011 | EP2275575A2 Coding sequence haplotypes of the human BRCA2 gene |
| 01/19/2011 | EP2275574A2 Coding sequence haplotypes of the human BRCA2 gene |
| 01/19/2011 | EP2275572A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours |
| 01/19/2011 | EP2275571A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours |
| 01/19/2011 | EP2275570A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours |
| 01/19/2011 | EP2275567A1 Nucleic acid expression construct and its use as a cell proliferation marker |
| 01/19/2011 | EP2275565A2 Nucleic acids encoding TGEV and PRRSV sequences for improved expression of PRRSV sequences |
| 01/19/2011 | EP2275564A1 Means and method for the production of transgenic plants that are resistant to clubroot |
| 01/19/2011 | EP2275563A2 Transgenic plant-based methods for plant insect pests using RNAi |
| 01/19/2011 | EP2275562A2 Transgenic plant-based methods for plant insect pests using RNAi |
| 01/19/2011 | EP2275561A1 Soybean Event MON89788 and methods for detection thereof |
| 01/19/2011 | EP2275560A2 Trangenic plants wherein the transgene is a memeber of the REMORIN gene family or a consensus sequence thereof having enhanced yield-related traits and a method for making the same |
| 01/19/2011 | EP2275559A2 Optimized messenger RNA |
| 01/19/2011 | EP2275558A2 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 01/19/2011 | EP2275557A1 Albumin fusion proteins |
| 01/19/2011 | EP2275556A1 Rapid screening method of translational fusion partners for producing recombinant proteins and translational fusion partners screened therefrom |
| 01/19/2011 | EP2275555A2 Genetic sequence coding for creatinine deiminase, and its use |
| 01/19/2011 | EP2275554A2 Neisserial antigenic peptides |
| 01/19/2011 | EP2275553A2 Neisserial antigenic peptides |
| 01/19/2011 | EP2275552A2 Neisserial antigenic peptides |
| 01/19/2011 | EP2275551A2 Neisserial antigenic peptides |
| 01/19/2011 | EP2275550A2 Variants of ADP-glucose pyrophosphorylase affecting phosphate sensitivity and other parameters |
| 01/19/2011 | EP2275549A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/19/2011 | EP2275548A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 01/19/2011 | EP2275546A2 Enzymatic DNA molecules |
| 01/19/2011 | EP2275545A1 Use of microRNA-24 and/or its targets for the treatment and prevention of ischemia and induction of angiogenesis |
| 01/19/2011 | EP2275544A2 Genes and polypeptides relating to human colon cancers |
| 01/19/2011 | EP2275543A2 Compositions and their uses directed to hepcidin |
| 01/19/2011 | EP2275542A2 Method for identifying useful proteins of brewery yeast |
| 01/19/2011 | EP2275541A2 Method for controlling the activity of immunologically functional molecule |
| 01/19/2011 | EP2275540A2 Method for controlling the activity of immunologically functional molecule |
| 01/19/2011 | EP2275539A2 A kit for judging risk for onset of drug-induced granulocytopenia |
| 01/19/2011 | EP2275538A1 Novel dna capable of being amplified by pcr with high selectivity and high efficiency |
| 01/19/2011 | EP2275537A1 Anti-human dlk-1 antibody having anti-tumor activity in vivo |
| 01/19/2011 | EP2275536A1 AP1 amine oxidase variants |
| 01/19/2011 | EP2275534A1 Novel strain of sars-associated coronavirus and applications thereof |
| 01/19/2011 | EP2275531A1 Method for proliferation of pluripotent stem cell |
| 01/19/2011 | EP2275450A1 Treatment with anti-ERBB2 antibodies |
| 01/19/2011 | EP2275449A1 Antibodies that immunospecifically bind to blys |
| 01/19/2011 | EP2275448A2 Monovalent antibody fragments useful as therapeutics |
| 01/19/2011 | EP2275446A2 Antibodies to insulin-like growth factor I receptor |